252 related articles for article (PubMed ID: 17785556)
21. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
[TBL] [Abstract][Full Text] [Related]
22. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia.
Grubach L; Juhl-Christensen C; Rethmeier A; Olesen LH; Aggerholm A; Hokland P; Ostergaard M
Eur J Haematol; 2008 Aug; 81(2):112-22. PubMed ID: 18410541
[TBL] [Abstract][Full Text] [Related]
24. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
[TBL] [Abstract][Full Text] [Related]
25. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
26. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
[TBL] [Abstract][Full Text] [Related]
27. Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia.
Diez-Martin JL; Dewald GW; Pierre RV
Am J Hematol; 1988 Mar; 27(3):194-203. PubMed ID: 3279762
[TBL] [Abstract][Full Text] [Related]
28. Hoxa6 potentiates short-term hemopoietic cell proliferation and extended self-renewal.
Dickson GJ; Kwasniewska A; Mills KI; Lappin TR; Thompson A
Exp Hematol; 2009 Mar; 37(3):322-33.e3. PubMed ID: 19157684
[TBL] [Abstract][Full Text] [Related]
29. Leukemogenic transformation by HOXA cluster genes.
Bach C; Buhl S; Mueller D; García-Cuéllar MP; Maethner E; Slany RK
Blood; 2010 Apr; 115(14):2910-8. PubMed ID: 20130239
[TBL] [Abstract][Full Text] [Related]
30. [Expression of pig7 in acute leukemia and its clinical significance].
Wang DH; Wang Y; Wang M; Liu H; Xu ZF; Rao Q; Meng JH; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):532-6. PubMed ID: 18078129
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
32. [Hoxa5: a master gene with multifaceted roles].
Boucherat O; Guillou F; Aubin J; Jeannotte L
Med Sci (Paris); 2009 Jan; 25(1):77-82. PubMed ID: 19154698
[TBL] [Abstract][Full Text] [Related]
33. HIC1 hypermethylation is a late event in hematopoietic neoplasms.
Issa JP; Zehnbauer BA; Kaufmann SH; Biel MA; Baylin SB
Cancer Res; 1997 May; 57(9):1678-81. PubMed ID: 9135007
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
35. The role of HOX genes in malignant myeloid disease.
Eklund EA
Curr Opin Hematol; 2007 Mar; 14(2):85-9. PubMed ID: 17255784
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
[TBL] [Abstract][Full Text] [Related]
37. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
39. Quantitative expression of the homeobox and integrin genes in human gastric carcinoma.
Rossi Degl'Innocenti D; Castiglione F; Buccoliero AM; Bechi P; Taddei GL; Freschi G; Taddei A
Int J Mol Med; 2007 Oct; 20(4):621-9. PubMed ID: 17786296
[TBL] [Abstract][Full Text] [Related]
40. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
